- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine ; volume:5 ; number:1 ; day:28 ; month:10 ; year:2008 ; pages:1-9 ; date:12.2008
Virology journal ; 5, Heft 1 (28.10.2008), 1-9, 12.2008
- Creator
-
Crevar, Corey J.
- Contributor
-
Ross, Ted M.
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-5-131
- URN
-
urn:nbn:de:1111-2016043045931
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Crevar, Corey J.
- Ross, Ted M.
- SpringerLink (Online service)
Other Objects (12)
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
A computational approach to design a multiepitope vaccine against H5N1 virus
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine